肝的抗生素治疗持续时间:系统性审查
Jennifer Curran1, Catherine Mulhall2, Ruxandra Pinto2
1Antimicrobial Stewardship Program, Sinai Health/University Health Network, Toronto, Ontario, Canada.
概括
对于发热性肝的抗生素治疗持续时间差异很大,平均为32.7天. 这种变异性并不能通过患者或感染特征来解释,这凸显了对最佳抗生素治疗的进一步研究的需要.
科学领域:
- 传染性疾病 传染性疾病
- 肝病学 肝病学是一种肝病学.
- 临床药理学 临床药理学
背景情况:
- 发烧性肝 (PLA) 是一种严重的腹内感染,需要及时治疗.
- 对PLA的最佳抗生素治疗持续时间仍未完全确定,导致实践变化.
研究的目的:
- 系统地审查和分析现有的关于抗生素治疗持续时间的肝脏的研究.
- 为了确定影响PLA抗生素治疗持续时间变化的因素.
主要方法:
- 2000年至2020年间发表的医学文献的系统审查和元分析.
- 采用随机效应元分析汇集了抗生素治疗持续时间的平均值.
- 超回归分析,以探索治疗持续时间和患者/病原体/的特征之间的关联.
主要成果:
- 参与3933名患者的16项研究提供了关于抗生素持续时间的数据.
- 平均抗生素持续时间范围广泛,从8.4至68.9天;综合平均值为32.7天 (95% CI 24.940.6),异质性非常高 (I2 = 100%).
- 在治疗持续时间和患者年龄之间没有发现显著的关联, *Klebsiella* spp. 患病率,瘤大小,多重性或管理策略.
结论:
- 目前的抗生素治疗实践存在显著的变化,用于发热性肝.
- 这种变异性并不能通过已知的患者,病原体或的特征来解释.
- 进一步的随机对照试验对于建立基于证据的指导方针来确定最佳的PLA抗生素治疗持续时间至关重要.
相关概念视频
Pulmonary Tuberculosis V
181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
411
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
411
Tonsillitis II: Management
114
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
114
Pneumonia IV: Management
333
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333
Pleural Effusion II: Symptoms and Management
183
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
183
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95


